Asset Advisors Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.12M Sell
39,874
-280
-0.7% -$32.8K 0.47% 49
2026
Q1
$4.83M Sell
40,154
-300
-0.7% -$34.6K 0.46% 52
2025
Q4
$4.26M Sell
40,454
-775
-2% -$72.8K 0.39% 50
2025
Q3
$3.46M Sell
41,229
-1,130
-3% -$93.1K 0.33% 52
2025
Q2
$3.35M Sell
42,359
-5,853
-12% -$465K 0.33% 50
2025
Q1
$4.33M Sell
48,212
-8,365
-15% -$781K 0.45% 48
2024
Q4
$5.63M Sell
56,577
-8,269
-13% -$852K 0.59% 43
2024
Q3
$7.36M Sell
64,846
-1,497
-2% -$178K 0.77% 37
2024
Q2
$8.21M Buy
66,343
+3,133
+5% +$404K 0.89% 34
2024
Q1
$8.34M Sell
63,210
-114
-0.2% -$14.1K 0.94% 32
2023
Q4
$6.9M Sell
63,324
-4,324
-6% -$449K 0.84% 29
2023
Q3
$6.96M Sell
67,648
-450
-0.7% -$48.5K 0.94% 29
2023
Q2
$7.86M Sell
68,098
-200
-0.3% -$22.7K 1% 30
2023
Q1
$7.27M Sell
68,298
-200
-0.3% -$21.6K 0.95% 31
2022
Q4
$7.6M Buy
68,498
+75
+0.1% +$7.67K 1% 32
2022
Q3
$5.89M Sell
68,423
-400
-0.6% -$35.7K 0.84% 32
2022
Q2
$6.28M Buy
68,823
+300
+0.4% +$26.6K 0.86% 32
2022
Q1
$5.62M Buy
68,523
+325
+0.5% +$25.6K 0.63% 41
2021
Q4
$5.23M Sell
68,198
-200
-0.3% -$15.9K 0.53% 44
2021
Q3
$5.14M Sell
68,398
-1,300
-2% -$98.9K 0.57% 43
2021
Q2
$5.42M Sell
69,698
-3,608
-5% -$268K 0.6% 45
2021
Q1
$5.34M Sell
73,306
-38,455
-34% -$2.84M 0.62% 41
2020
Q4
$8.72M Buy
111,761
+4,968
+5% +$380K 1.13% 31
2020
Q3
$8.45M Buy
106,793
+4,454
+4% +$349K 1.28% 27
2020
Q2
$7.55M Buy
102,339
+2,555
+3% +$192K 1.21% 31
2020
Q1
$7.33M Buy
99,784
+6,513
+7% +$512K 1.36% 27
2019
Q4
$8M Buy
93,271
+1,162
+1% +$95.4K 1.16% 31
2019
Q3
$7.4M Buy
92,109
+688
+0.8% +$55.1K 1.18% 29
2019
Q2
$7.32M Sell
91,421
-1,077
-1% -$82.5K 1.23% 26
2019
Q1
$7.34M Sell
92,498
-340
-0.4% -$25.4K 1.31% 26
2018
Q4
$6.77M Hold
92,838
1.34% 25
2018
Q3
$6.28M Buy
+92,838
New +$5.91M 1.04% 33

Other funds holding MRK

Asset Advisors Investment Management's MRK Position: Q2 2026 in Review

Asset Advisors Investment Management reduced its Merck (MRK) stake by 0.7% in Q2 2026, selling an estimated $32.8K and leaving 39,874 shares worth $5.12M. The position accounts for 0.47% of the portfolio, ranked #49.

Asset Advisors Investment Management first reported a position in MRK in Q3 2018 and has held it in 32 quarters since. The position peaked at $8.72M in Q4 2020. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Asset Advisors Investment Management held 39,874 shares of Merck worth $5.12M as of Q2 2026.
  • Asset Advisors Investment Management sold 280 Merck shares in Q2 2026, an estimated $32.8K.
  • Merck made up 0.47% of Asset Advisors Investment Management's portfolio in Q2 2026, its #49 holding.
  • Asset Advisors Investment Management first reported a position in Merck in Q3 2018 and has held it in 32 quarters since.
  • Asset Advisors Investment Management's Merck position peaked at $8.72M in Q4 2020.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Asset Advisors Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.